Columns & Departments
IP News
Appeals Court Backs Nickelback In Copyright Infringement Case
Features

FTC Chair Concerned About Dominant Tech Firms
The concentration of dominant technology firms could harm U.S. national interests and global leadership, Federal Trade Commission Chair Lina Khan said in March at a Carnegie Endowment for International Peace event.
Features

Law Firms' Pressing AI Questions
Most of the legal industry has by now boarded the generative artificial intelligence train, filling up conference sessions dedicated to the topic, testing new legal technology solutions and exploring the emerging legal questions that the technology will pose. But most of their questions about generative AI are still unanswered.
Columns & Departments
Co-ops and Condominiums
Housing Discrimination Claim Dismissed Co-Op Did Not Breach Shareholder's Guaranty Agreement Co-Op Not Exempt from Lead Paint Mandate
Columns & Departments
Bit Parts
Amazon Didn't Exceed Scope of License to Stream Chinese Drama California Talent Agency's Lawsuit in Texas Won't Be Stayed Pending Proceeding Before California Labor Commissioner King Holmes Fires Back at Band's Legal Malpractice Complaint No Substantial Similarity Found Between TV Show Abbott Elementary and Plaintiff's Teacher-Focused Treatment for Proposed TV Series
Features

Law Firms Happy to Trade Falling Realization Rates for Strong Rate Increases
While some firm leaders pointed to market factors such as economic uncertainty, most indicated that declining realization rates were a price they were happy to pay in exchange for several years of strong rate increases.
Features

Law Firm Offices Continued to Shrink In 2023, But Real Estate Costs Did Not
Despite the overall trend of downsizing, about 42% of the 80 Am Law 200 firms increased their real estate footprints in 2023. Proportionally, the downsizing was more aggressive than the footprint growth.
Features

An Early Look: The 2024 Am Law 200 Financials
As firm financials results stream in, we're covering them firm by firm, as we've always done. You can read those story in this continually updated feed. So bookmark it, check back regularly, and stay tuned for the Am Law 100 and Second Hundred reports coming soon.
Features

AI Needs Its 'Come to Jesus' Moment
It's time to stop the hype, stop talking up AI as if it's the next best thing since sliced bread and prove that it's a useful tool and technology that can actually be used in the actual practice of law.
Features

Sui Generis: Draft Like You Mean It
The automatic acceptance of various boilerplate clauses in commercial leases in the face of jurisprudential modernity and evolving legal approaches is dangerous. The evolutionary exploits of a commercial lease aren't done yet, nor should they be.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Protecting Innovation in the Cyber World from Patent TrollsWith trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.Read More ›
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›